Searching for the Holy Grail: Where do we go with the current biomarkers for sepsis?

Revista Brasileira de Terapia Intensiva

Volumn 24, Issue 2, 2012, Pages 117-118

  Dal Pizzol, Felipe ^a,b   Ritter, Cristiane ^a,b  

^a HOSPITAL SÃO JOSÉ   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873900081     PISSN: 0103507X     EISSN: 19824335     Source Type: Journal    
DOI: 10.1590/S0103-507X2012000200004     Document Type: Editorial

References (6)

1. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14(1):R15.
2. Marshall JC, Reinhart K; International Sepsis Forum. Biomarkers of sepsis. Crit Care Med. 2009;37(7):2290-8. Review.
3. Martin JG, Kurokawa CS, Carpi MF, Bonatto RC, Moraes MA, Fioretto JR. Interleucina-12 em crianças com sepse e choque séptico. Rev Bras Ter Intensiva. 2012;24(2):130-6.
4. Soares M, Lisboa T, Salluh JI. Translating the PIRO staging system concept into clinical practice: where do we go from here Crit Care Med. 2011;39(2):408-9.
5. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007;11(2):R49.
6. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC; GenIMS Investigators. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):1655-63.